| Literature DB >> 33842544 |
Marie-Laure Fogeron1, Lauriane Lecoq1, Laura Cole1, Matthias Harbers2,3, Anja Böckmann1.
Abstract
Cell-free protein synthesis (CFPS) systems are gaining more importance as universal tools for basic research, applied sciences, and product development with new technologies emerging for their application. Huge progress was made in the field of synthetic biology using CFPS to develop new proteins for technical applications and therapy. Out of the available CFPS systems, wheat germ cell-free protein synthesis (WG-CFPS) merges the highest yields with the use of a eukaryotic ribosome, making it an excellent approach for the synthesis of complex eukaryotic proteins including, for example, protein complexes and membrane proteins. Separating the translation reaction from other cellular processes, CFPS offers a flexible means to adapt translation reactions to protein needs. There is a large demand for such potent, easy-to-use, rapid protein expression systems, which are optimally serving protein requirements to drive biochemical and structural biology research. We summarize here a general workflow for a wheat germ system providing examples from the literature, as well as applications used for our own studies in structural biology. With this review, we want to highlight the tremendous potential of the rapidly evolving and highly versatile CFPS systems, making them more widely used as common tools to recombinantly prepare particularly challenging recombinant eukaryotic proteins.Entities:
Keywords: NMR; cell-free protein expression; labeling; structural biology; wheat germ
Year: 2021 PMID: 33842544 PMCID: PMC8027086 DOI: 10.3389/fmolb.2021.639587
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1Components of WG-CFPS described by Takai et al. (2010). (A) Wheat germ extract (WGE) can be prepared from nontreated durum wheat. Alternatively, commercially available WGE can be used. (B) The WG-CFPS uses expression templates having a SP6 promoter to drive RNA synthesis and an E01 translational enhancer to induce cap-independent translation. The system can use circular and linear DNA templates to hold a cDNA encoding a protein. Alternatively, T7 RNA polymerase can be used as well under the same reaction conditions. The RNA is used as a template for protein synthesis. (C) The key components for protein synthesis are provided with the WGE. This includes the necessary ribosomes and tRNAs, but there are also other cell components in those extracts that may assist for example protein folding or possibly protein modification. Other key components are provided by the “Buffered Substrate Solution” which includes the amino acids, a DTT-based redox system, and a creatine kinase driving energy supply. Protein synthesis reactions can be modified as further explained in the text. (D) Protein synthesis can be confirmed by several different methods with the most commonly ones given in the figure.
FIGURE 2Workflow to establish protein synthesis in a WGS, with key points given at each step.
Protein analysis tools and selected databases.
| Tool | Description | URL |
|---|---|---|
| Gene | Reference database and resources |
|
| UniProt | Protein sequence and functional information |
|
| Wheat proteome | Reference on background protein analysis |
|
| Protein Chemistry | Links to useful tools |
|
| ProtParam tool | Calculating physical and chemical parameters |
|
| Mfold | RNA folding |
|
| JPred | Protein secondary structure prediction |
|
| Espript | Alignment and secondary structure prediction |
|
| Protter | Visualization of proteoforms |
|
| Sable | Solvent accessibility |
|
| Scratch | Protein predictor on protein structures |
|
| InterPro | Protein classification and predicting domains |
|
| FFAS | Folding and function assignment |
|
| CDTree | Protein domain hierarchy viewer and editor |
|
| Cn3D | Macromolecular structure viewer |
|
| VaProS | Variation effect on Protein structure and function |
|
| PSIPRED | Protein sequence analysis workbench |
|
| PONDR | Predictor of natural disordered regions |
|
| Protein data bank | 3D structures of proteins |
|
| PyMOL | Molecular visualization system |
|
| TM finder | Transmembrane region finder |
|
FIGURE 3Template design for expression of the protein of interest. (A) Design of the gene sequence. (B) Both circular and linear DNA templates can be used for transcription.
Summary of tags whose use has been described for protein expression with the WGS.
| Tag Examples of applications for WG-CFPS | Parameters to be considered for the choice of a tag | ||||
|---|---|---|---|---|---|
| Type | Main types of application | Position | References | Advantages | Drawbacks |
| Single tag | |||||
| His6 | Translation setup and protein detection Purification by affinity chromatography | N-ter C-ter | ( | Cost effective, easy, and fast purification process | WGE endogenous proteins bind to the affinity support |
| GST | Translation setup at small scale | N-ter | ( | Solubility enhancement | WGE endogenous proteins bind to the affinity support |
| HaloTag | Pull-down assays | N-ter | ( | Covalent bound, elution by enzymatic cleavage allowing for stringent washing conditions | Large size of the tag (34 kDa) |
| FLAG | Functional analysis | N-ter | ( | No binding of WGE endogenous proteins to the affinity support elution by enzymatic cleavage or by competition high protein recovery and high purity level in a only one-step purification process | Lower binding capacity of the affinity support |
| C-ter | ( | ||||
| Strep-tag II | Purification by affinity chromatography | N-ter | ( | No binding of WGE endogenous proteins to the affinity support | Slightly lower binding capacity of the affinity support than for His- and GST-tags |
| C-ter | ( | ||||
| Dual tag | |||||
| Double-His6 | Purification by affinity chromatography | N-ter | ( | Improved binding capacity | |
| GST-His6 | Pull-down assays | N-ter/C-ter | ( | Solubility enhancement through GST | |
| GST-AviTag | Pull-down assays | N-ter/C-ter | ( | Solubility enhancement through GST | |
| His-Flag |
| N-ter | ( | Efficient purification through His-tag | |
| Flag-His | Structural analysis by cryo-EM and crystallography | N-ter/C-ter | ( | Two-step affinity purification for higher purity | |
| Twin-Strep-tag | Functional analysis | C-ter | ( | Higher affinity than Strep-Tag | |
| His6-MBP | Purification by affinity chromatography | N-ter | ( | Solubility enhancement through MBP | |
GST, glutathione S-transferase; MBP, maltose-binding protein; WGE, wheat germ extract.
FIGURE 4Protein analysis. (A) Typical flowchart for protein analysis after small-scale expression test. Parameters to be considered are highlighted in blue. (B) Small-scale expression test of the nonstructural protein 2 (NS2) from hepatitis C virus (HCV). This membrane protein was produced in the absence or presence of various detergents at a 0.1% concentration (w/v). Samples were analyzed by SDS-PAGE followed by Coomassie blue staining (upper panels) and Western blotting with an antibody against the Strep-tag II fused at the C-terminus of NS2 (lower panels). CFS, total cell-free sample; pellet, pellet obtained after centrifugation of CFS; SN-beads, supernatant obtained after centrifugation of CFS and incubated with Strep-Tactin magnetic beads to capture Strep-tag II-tagged NS2 protein; −, negative control (no NS2); +, positive control (NS2 expressed in the absence of detergent). The black arrowheads indicate NS2, adapted from Fogeron et al. (2015a). (C) SDS-PAGE analysis followed by Coomassie blue staining of the different steps from the affinity purification of the NS2 membrane protein produced directly in a solubilized form in the presence of MNG-3, adapted from Fogeron et al. (2015b).
Maximal concentration for added ions.
| Ion | Salt | Maximal concentration (µM) |
|---|---|---|
| Mn2+ | Chloride | 100 |
| Acetate | 100 | |
| Mg2+a | Chloride | 100 |
| Acetate | 100 | |
| Ca2+ | Chloride | 100 |
| Acetate | 100 | |
| Cu2+ | Chloride | 100 |
| Acetate | 100 | |
| Cd2+ | Chloride | 100 |
| Acetate | 100 | |
| Co2+ | Chloride | 100 |
| Acetate | 100 | |
| Fe2+b | Chloride | 10 |
| Ni2+ | Chloride | 100 |
| Acetate | 100 | |
| Zn2+ | Chloride | 10 |
| Acetate | 100 |
Data obtained for expression of GFP using wheat germ extract WEPRO7240 (CellFree Sciences, Japan) on a bilayer format.
aCFPS systems are critically dependent on the Mg concentration.
bAbout 25% reduction of protein yield when using 100 µM ferrous chloride.
Summary of detergents whose use has been described to produce membrane proteins with the WGS.
| Detergents | Proteins | Yield | Solubility | References | Applications/comments | |
|---|---|---|---|---|---|---|
|
| ||||||
| Cholate | 3,7,12-Trihydroxy-5-cholan-24-oic acid | AtPPT1 | ▽ | ( | ||
| Insect odorant receptor subunits | – | ( | ||||
| Nonstructural proteins from HCV | ▽ | ( | Protein expression | |||
| Deoxycholate | 3,12-Dihydroxy-5-cholan-24-oic acid | Insect odorant receptor subunits | – | ( | ||
| N-Lauryl sarcosine | Insect odorant receptor subunits | ▲ | ( | Not suitable for functional or structural studies | ||
| SDS | Sodium dodecyl sulfate | Insect odorant receptor subunits | ▲ | ( | Not suitable for functional or structural studies | |
|
| ||||||
| CHAPS | Steroid derivative (3-((3-cholamidopropyl)dimethylammonio)-1-propansulfonat) | AtPPT1 | ▽ | ( | ||
| Bacteriorhodopsin | ▽ | ( | ||||
| CrdS ( | ▽ | ( | Protein expression | |||
| Nonstructural proteins from HCV | ▽ | ( | ||||
| CD36 | ▽ | ▲ | CFS | |||
| EDG3; GPR84 | ▽ | CFS | ||||
| DPC | Monochain phosphocoline (dodecyl-phosphocholine) | Nonstructural proteins from HCV | ▽ | ( | Protein expression | |
| LDAO | Lauryl dimethyl amide oxide | Nonstructural proteins from HCV | ▽ | ( | Protein expression | |
| LPPG | 1-Palmitoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] | F2R, CDC91L1, EDG3, PINK1, CCR7, GPR84 | ▲ | CFS | ||
| Zwittergent 3–16 | Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | ||
|
| ||||||
| Brij-35 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| Bacteriorhodopsin | ▲ | ( | ||||
| hSCD1 (human stearoyl-CoA desaturase) | ▲ | ( | ||||
| Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | |||
| F2R, CDC91L1, CD36, PINK1, CCR7, and GPR84 | ▲ | CFS | ||||
| EDG3 | ▲ | ▲ | CFS | |||
| Brij-58 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| Olfactory receptors (GPCRs) | ▽ | ▲ | ( | |||
| Bacteriorhodopsin | – | ( | Protein not functional | |||
| CrdS ( | ▲ | ( | Insertion of purified protein into nanodiscs | |||
| Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | |||
| F2R, CDC91L1, CD36, PINK1, CCR7, and GPR84 | ▲ | CFS | ||||
| EDG3 | ▲ | ▲ | CFS | |||
| Brij-78 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | |||
| Brij-97 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| Brij-98 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | |||
| C12E8 | Dodecyl octaethylene glycol ether | Nonstructural proteins from HCV | ▲ | ( | Protein expression | |
| Digitonin | Steroid derivative | AtPPT1 | ▽ | ▲ | ( | |
| Olfactory receptors (GPCRs) | ▲ | ( | ||||
| Bacteriorhodopsin | – | ( | Protein not functional | |||
| CrdS ( | ▲ | ( | ||||
| Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | |||
| F2R, CDC91L1, CD36, EDG3, PINK1, CCR7, and GPR84 | ▲ | ▲ | CFS | |||
| DM | Alkyl glucoside (n-decyl-D-maltoside) | Bacteriorhodopsin | ▽ | ▲ | ( | |
| Nonstructural proteins from HCV | ▽ | ( | Protein expression | |||
| DDM | Alkyl glucoside (n-dodecyl-D-maltoside) | AtPPT1 | ▽ | ( | ||
| Bacteriorhodopsin | ▽ | ▲ | ( | |||
| hVDAC1 | ▽ | ▲ | ( | Protein crystallization | ||
| AAC (ADP/ATP carrier) | ▽ | ( | ||||
| Insect odorant receptor subunits | – | ( | Insertion of purified proteins into preformed liposomes | |||
| Nonstructural proteins from HCV | ▽ | ▲ | ( | Protein expression | ||
| F2R | ▽ | ▲ | CFS | |||
| MNG-3 | Lauryl maltose neopentyl glycol | Bacteriorhodopsin | ▲ | ( | ||
| Nonstructural proteins from HCV | ▲ | Structural analysis by NMR | ||||
| Functional analysis | ||||||
| Envelope proteins from duck hepatitis B virus | ▲ | ( | ||||
| Nonidet P-40 | Polyethylene glycol derivative | AtPPT1 | ▽ | ▲ | ( | |
| CrdS ( | ▽ | ( | ||||
| CDC91L1 | ▽ | CFS | ||||
| CD36, EDG3, and PINK1 | ▲ | CFS | ||||
| CCR7 and GPR84 | ▽ | ▲ | CFS | |||
| β-OG | Alkyl glucoside (n-octyl- | Insect odorant receptor subunits | – | ( | ||
| CrdS ( | ▽ | ( | ||||
| Nonstructural proteins from HCV | ▽ | ( | Protein expression | |||
| EWSR1, CDC91L1, CD36, PINK1, and GPR84 | ▽ | CFS | ||||
| Triton X-100 | Polyethylene glycol derivative | AtPPT1 | ▽ | ▲ | ( | |
| CrdS ( | ▲ | ( | ||||
| Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | |||
| F2R | ▽ | ▲ | CFS | |||
| CDC91L1, CD36, EDG3, PINK1, CCR7, and GPR84 | ▲ | CFS | ||||
| Triton X-114 | Polyethylene glycol derivative | Insect odorant receptor subunits | ▲ | ( | Insertion of purified proteins into preformed liposomes | |
| Tween-20 | Polyoxyethylene alkyl-ether | AtPPT1 | ▽ | ( | ||
| F2R, CD36, PINK1, and CCR7 | ▽ | ▲ | CFS | |||
| EWSR1, CDC91L1, and GPR84 | ▽ | CFS | ||||
| EDG3 | ▲ | CFS | ||||
| Tween-40 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| Tween-60 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| Tween-80 | Polyoxyethylene alkyl-ether | AtPPT1 | ▲ | ( | ||
| CrdS ( | ▲ | ( | ||||
|
| ||||||
| Fos-choline | FC-12 or FC-14 | Bacteriorhodopsin | ▲ | ( | Counteracting the inhibitory effect of detergent | |
| CHAPS | ||||||
▽, decrease in yield or solubility.
▲, increase in yield or solubility.
–, no effect on solubility level.
HCV, hepatitis C virus. CFS, CellFree Sciences (M. Denda et al., poster presentation at PepTalk 2011).
Summary of lipids whose use has been described for the production of membrane proteins with the WGS.
| Lipid composition | Proteins | References | Applications/comments |
|---|---|---|---|
|
| |||
| DOPG | CrdS ( | ( | No protein expression |
|
| |||
| DOTAP | CrdS ( | ( | No protein expression |
|
| |||
| Asolectin | AtPPT1 ( | ( | Functional analysis |
| Isolation on density gradient | |||
| AtDTC ( | ( | ||
| PfDTC ( | ( | Transport activity | |
| CrdS ( | ( | ||
| Human dopamine D1 receptors | ( | Receptor binding activity | |
| Ant1p ( | ( | Transport activity of ATP/AMP exchange | |
| DMPC | Bacteriorhodopsin | ( | Bacteriorhodopsin not functional |
| CrdS ( | ( | ||
| DOPC | Cytochrome b5 | ( | Transport activity |
| CrdS ( | ( | ||
| EYPC | Cytochrome b5 | ( | Transport activity |
| POPC | CrdS ( | ( | |
| POPE | CrdS ( | ( | |
|
| |||
| Soybean total extract, containing 20% lecithin | Human stearoyl-CoA desaturase complex | ( | Functional and structural analysis by NMR |
| TbSLS4 ( | ( | Enzymatic specificity analysis | |
| PilD ( | ( | Enzymatic activity | |
|
| ( | Oocyte injection | |
| AtRGS1 ( | ( | Functional and biochemical analysis | |
| DMPC/cholesterol (70/30, mol/mol) | Cytochrome b5 | ( | Transport activity |
| DOPG/POPE (2/3, w/w) | CrdS ( | ( | |
| POPC/CL/POPS/POPA (54/24/16/4/2, mol/mol) | AAC (ADP/ATP carrier) | ( | Transport activity |
|
| CrdS ( | ( | |
|
| |||
| Asolectin liposomes | AtPPT1 ( | ( | |
|
| |||
| Asolectin/20% glycerol (glycerosome) | HRH1 (human histamine H1 receptor, GPCR) | ( | New drug delivery system |
|
| |||
| MSP1D1 | AtRGS1 ( | ( | Functional and biochemical analysis |
| MSP1E3D1 | Tim23 (subunit of the TIM23 protein transport complex) | ( | Functional and structural characterization |
Liposomes. DOPG (1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)); DOTAP, 1,2-dioleoyl-3-trimethylammonium-propane; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DOPC, 1,2-di-oleoyl-sn-glycero-3-phosphocholine; EYPC, egg yolk phosphatidylcholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine; CL, 19,39-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol; POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine; POPA, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate.
Nanodiscs. MSP1D1, membrane scaffold protein 1D1; MSP1E3D1, membrane scaffold protein 1E3D1; TOCL, 1′,3′-bis[1,2-dioleoyl-sn-glycerol-3-phospho-]-sn-glycerol.
FIGURE 5Different reaction formats for protein expression using the WGS. (A) Schematic representation and (B) picture of a 500 μL dialysis cassette for medium scale CECF production. (C) Schematic representation of the bilayer method which is performed either in a 96-well plate for small-scale expression test or in a 6-well plate for larger-scale production (D), adapted from Fogeron et al. (2015a), Fogeron et al. (2015b); Fogeron et al. (2017b). (E) Schematic representation of the dialysis method and (F) picture of a CECF mini-reactor manufactured at ETH Zurich by Andreas Hunkeler in Beat H. Meier’s laboratory, according to Schneider et al. (2009). In this reaction format, a 24-well plate is used. For all panels, the translation mix is represented in yellow while the feeding buffer is represented in blue.
FIGURE 6Structural characterization of proteins produced from cell-free protein expression.
FIGURE 7Examples of structural studies on proteins expressed in WGS using NMR, X-ray crystallography, and cryo-EM. (A) Solid-state NMR spectrum of the HCV membrane protein NS4B reconstituted into DMPC lipids (Jirasko et al., 2020). (B) Dimer orientation in lipids of the HCV helix anchor and domain 1 (AHD1) of the NS5A protein as determined by solid-state NMR (Jirasko et al., 2020). (C) Solid-state NMR spectra of the hepatitis B virus capsid (Wang et al., 2019) and of (D) the subviral particles made of duck HBV small envelope protein (DHBs S) (David et al., 2018). The three spectra have been recorded at 110 kHz MAS on an 850 MHz spectrometer. Both HBV capsids and subviral particles were autoassembled during cell-free synthesis; their negative-staining electron microscopy images are shown inside the corresponding spectrum. (E) 20 conformers obtained by solution NMR of At3g01050.1 protein (Vinarov et al., 2004) (PDB 1se9, figure prepared using PyMoL (https://pymol.org/2/). (F) Structure of restriction endonuclease PabI obtained by X-ray crystallography (Miyazono et al., 2007; Watanabe et al., 2010) (PDB 2dvy). (G) 3D cryo-EM reconstruction of PDX1.2 complex at 15 Å resolution (Novikova et al., 2018). Figures were adapted with permission from Jirasko et al. (2020) for panel A, from Wang et al. (2019) for panel C, and from David et al. (2018) for panel D and reprinted with permission from Jirasko et al. (2020) for panel D, from Miyazono et al. (2007), Watanabe et al. (2010) for panel F, and from Novikova et al. (2018) for panel G.